BioCorRx Inc. financial data

Symbol
BICX on OTC
Location
2390 East Orangewood Avenue, Suite 570, Anaheim, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q1 2025 - May 15, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 3.25 % -19.2%
Debt-to-equity -120 % -12.2%
Return On Equity 40.7 % -1.17%
Return On Assets -232 % +71%
Operating Margin -3.66K % +48.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 16.1M shares +82.6%
Common Stock, Shares, Outstanding 16.9M shares +89.9%
Entity Public Float 2.72M USD -70.5%
Common Stock, Value, Issued 16.9K USD +89.9%
Weighted Average Number of Shares Outstanding, Diluted 3.55M shares +20.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 139K USD +165%
Cost of Revenue 0 USD -100%
Research and Development Expense 1.43M USD +65%
General and Administrative Expense 711K USD -27.6%
Operating Income (Loss) -5.09M USD -37.6%
Nonoperating Income (Expense) 265K USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -4.83M USD -20.7%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -4.82M USD -20.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Accounts Receivable, after Allowance for Credit Loss, Current 112K USD
Inventory, Net 134K USD
Assets, Current 566K USD +273%
Property, Plant and Equipment, Net 15.2K USD -65.8%
Operating Lease, Right-of-Use Asset 189K USD +168%
Goodwill 2.84M USD
Assets 6.8M USD +2042%
Accounts Payable, Current 2.97M USD +7.01%
Liabilities, Current 13.4M USD +87.6%
Operating Lease, Liability, Noncurrent 149K USD
Liabilities 18.6M USD +66.3%
Retained Earnings (Accumulated Deficit) -84.1M USD -5.94%
Stockholders' Equity Attributable to Parent -11.6M USD -7.62%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -11.8M USD -8.59%
Liabilities and Equity 6.8M USD +2042%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -690K USD -103%
Net Cash Provided by (Used in) Financing Activities 626K USD +66.6%
Common Stock, Shares Authorized 750M shares 0%
Common Stock, Shares, Issued 16.9M shares +89.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 24.1K USD -76.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 722 USD -91.6%
Deferred Tax Assets, Valuation Allowance 12.3M USD +9.97%
Deferred Tax Assets, Gross 12.4M USD +8.39%
Operating Lease, Liability 209K USD +197%
Depreciation 29.3K USD +14.1%
Lessee, Operating Lease, Liability, to be Paid 223K USD +106%
Property, Plant and Equipment, Gross 195K USD 0%
Operating Lease, Liability, Current 40.9K USD -60.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 40.9K USD +271%
Lessee, Operating Lease, Liability, to be Paid, Year One 13.6K USD -65.3%
Deferred Income Tax Expense (Benefit) 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 54.5K USD
Deferred Tax Assets, Operating Loss Carryforwards 8.25M USD +3.51%
Preferred Stock, Shares Issued 160K shares
Preferred Stock, Shares Authorized 600K shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 54.5K USD
Operating Lease, Payments 4.55K USD
Additional Paid in Capital 72.4M USD +5.67%
Preferred Stock, Shares Outstanding 160K shares
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 216K USD +125%
Interest Expense 682K USD +95.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares